Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms
COVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the di...
Saved in:
Main Authors: | A. E. Babushkin, L. I. Gilemzianova, I. P. Ponomarev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Real Time Ltd
2024-07-01
|
Series: | Российский офтальмологический журнал |
Subjects: | |
Online Access: | https://roj.igb.ru/jour/article/view/1499 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous mucormycosis: Unveiling rare manifestations
by: Jyoti Jindal, et al.
Published: (2025-06-01) -
Double Jeopardy: Cutaneous Mucormycosis in a Renal Transplant Patient Post-COVID-19
by: Radha Vijayaraghavan, et al.
Published: (2025-04-01) -
Invasive Mucormycosis with Lung Involvement in a Female Patient with Aplastic Anemia
by: Zh. V. Sheikh, et al.
Published: (2019-09-01) -
Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study
by: S. N. Khostelidi, et al.
Published: (2022-07-01) -
Eye damage in COVID-19. Part 1: Involvement of the eye in SARS-CoV-2 virus transmission and anterior segment complications
by: N. I. Kurysheva, et al.
Published: (2022-12-01)